INTS
INTENSITY THERAPEUTICS, INC.
+0.09 (+2.36%)3.90USD2.4K成交股數12.7M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 1.8M | 1.2M | 1.5M | 1.6M | 1.5M | 2.2M | 2.2M | 3.6M | 2.8M | 1.8M | 1.4M | 859K |
| 銷售管理費用 | 1.3M | 1.3M | 1.6M | 1.2M | 1.2M | 1.2M | 1.4M | 1.5M | 1.9M | 1.6M | 1.1M | 362K |
| 營業利益 | −3.1M+14% | −2.5M-26% | −3.1M-12% | −2.7M-46% | −2.7M-43% | −3.4M+1% | −3.6M+43% | −5.1M+315% | −4.7M | −3.4M | −2.5M | −1.2M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −3.0M+19% | −2.4M-27% | −3.1M-13% | −2.7M-46% | −2.5M-45% | −3.3M+6% | −3.5M+51% | −5.0M+34% | −4.6M | −3.2M | −2.3M | −3.7M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -1.11-67% | -0.96-83% | 0.37-248% | -0.06-83% | -3.36+888% | -5.51-1003% | -0.25+47% | -0.36-75% | -0.34 | 0.61 | -0.17 | -1.43 |
| 稀釋股數 | 2.7M | 2.5M | 1.4M | 43.0M | 755K | 607K | 13.8M | 13.7M | 13.7M | 8.6M | 13.7M | 3.5M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 9.5M | 10.2M | 11.9M | 7.1M | 2.2M | 929K | 2.8M | 3.2M | 7.5M | 8.6M | 6.7M | 136K |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 11.5M | 12.3M | 14.1M | 9.6M | 4.4M | 3.1M | 5.2M | 8.7M | 12.4M | 17.3M | 16.8M | 18.2M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 2.3M | 2.3M | 2.2M | 2.4M | 2.3M | 2.7M | 2.4M | 3.3M | 2.7M | 4.1M | 905K | 3.1M |
| 股東權益 | 9.2M | 10.0M | 11.9M | 7.2M | 2.2M | 334K | 2.8M | 5.3M | 9.7M | 13.2M | 15.9M | 15.1M |
| 負債比 | 20.0% | 18.8% | 15.8% | 24.7% | 50.8% | 89.1% | 46.7% | 38.4% | 21.6% | 23.9% | 5.4% | 17.0% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −1.8M-8% | – | – | – | −2.0M | – | – | −4.4M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −11.6M | –% | -8.56 | – |
| FY2024 | – | – | −16.3M | –% | -29.24 | – |
| FY2023 | – | – | −10.5M | –% | -1.38 | – |
| FY2022 | – | – | −7.6M | –% | -2.22 | – |